Hangzhou, China – AREX Biosciences, a leading domestic supplier of high-quality immunohistochemistry (IHC) pathology raw materials, will make its international debut at the 2026 European Congress of Pathology (ECP) in Stockholm, Sweden, taking place September 12–16, 2026. The company will showcase its full pathology solution portfolio at Booth 540, marking its official first step in 2026 global market expansion.
Unlike many brands focused on ready-to-use reagents, AREX adheres to a clear strategic focus: it exclusively provides high-concentrated raw material products, with no pre-diluted antibodies or working solutions. This positioning grants downstream laboratories and IVD partners full flexibility for formula customization, dilution optimization, and platform adaptation, ensuring both cost efficiency and experimental compatibility.
At ECP 2026, AREX will present its three core modular product lines: IHC Antibodies (Raw), the company’s flagship offering including tissue-classified panels and proprietary series (AREXBs, AREXDs, AREXRs). All concentrated raw antibodies have been rigorously validated in China’s large-scale clinical pathology market. AREXVisual® System is a complete in-house developed detection platform, and Ancillaries covers a full range of supporting reagents for the entire IHC workflow.
With years of proven performance in China’s pathology diagnostic sector, AREX is eager to connect with European pathologists, research labs and IVD industry partners. The AREX team warmly welcomes all attendees to visit Booth 540, explore its product portfolio, discuss raw material cooperation opportunities, and exchange insights on histopathological diagnostic technology.
Post time: 2025-04-30 10:24:33
- Previous:
- Next: AREX showed in the 2025 CSP Annual Meeting
